Abstract

Research Article

Clinical characteristics of patients with respiratory disease and probable COVID-19 at the General Hospital Zacatecas Mexico

Ruvalcaba-González AP, Escalera-López Fde J, Macias-Ortega BI and Araujo-Conejo A*

Published: 04 May, 2023 | Volume 7 - Issue 1 | Pages: 007-014

Introduction: The spread of SARS-CoV-2 cases grew exponentially. In Mexico, it focused mainly on containing the disease and adopting activities and actions to mitigate it. Hospital reconversion was a fundamental strategy in the management of care for patients with COVID-19.
Objective: To know the clinical characteristics of patients admitted with respiratory disease and probable COVID-19 in the Zacatecas General Hospital “Luz González Cosío” México.
Material and methods: Descriptive, cross-sectional, and analytical study, at the General Hospital, from March 2019 to September 2021; using data from the Respiratory Disease Surveillance System. Data from patients admitted with a diagnosis of some pathology of respiratory disease and probable COVID-19 were analyzed.
Results: We included 2,678 diagnosed with respiratory disease and a mean age; of 47.6 ± 21.6 gender distribution was almost equal; women 1,344 (51.0%). positive result to COVID-19 by PCR; 1,654 negatives; 900 and 124 without result. 193 (7.0%) required mechanical ventilation. The presence of comorbidities was evaluated; type 2 diabetes mellitus, systemic arterial hypertension, obesity, alone and together. Also the association of the age factor, as well as the lethality index; was 531 (19.6%).
Discussion: What has been published in other studies about comorbidities and their influence on the severity of COVID-19 is confirmed, disagreeing on the case fatality rate; 20.7% against what was reported; 17.6% in other countries for COVID-19 hospitalized. An age variable was used as a risk factor with a cut-off point > 45 years; (FRE), obtaining; RR 3.42 (95% CI 2.79 to 4.19) and an odds ratio of 4.015 in binary logistic regression analysis. Reported male mortality (OR = 1.45; 95% CI: 1.41–1.51) according to our OR results; 1,45.
Conclusion: The present study shows how certain chronic diseases influenced respiratory disease to present a serious state, regardless of the positive or negative result of COVID-19.

Read Full Article HTML DOI: 10.29328/journal.aceo.1001014 Cite this Article Read Full Article PDF

Keywords:

Comorbidities; COVID-19; Diabetes mellitus (DM); Systemic arterial hypertension (SAH); Obesity (OB); SARS-CoV-2

References

  1. Mohan SV, Hemalatha M, Kopperi H, Ranjith I, Kumar AK. SARS-CoV-2 in environmental perspective: Occurrence, persistence, surveillance, inactivation and challenges. Chem Eng J. 2021 Feb 1;405:126893. doi: 10.1016/j.cej.2020.126893. Epub 2020 Sep 4. PMID: 32901196; PMCID: PMC7471803.
  2. World health organization. Who disease outbreak news: novel coronavirus – republic of Korea (ex-china). January 21, 2020. Https://www.who.int/csr/don/21-january-2020-novel-coronavirus-republic-of-korea-ex-china/en/.
  3. https://coronavirus.jhu.edu/map.html
  4. Remes-Troche JM, Velarde-Ruiz Velasco JA. The Liver and COVID-19 in Mexico. Clin Liver Dis (Hoboken). 2021 Aug 27;19(2):49-52. doi: 10.1002/cld.1153. PMID: 34900238; PMCID: PMC8653117.
  5. https://coronavirus.jhu.edu/map.html. 2021.
  6. Rodriguez-Morales AJ, Gallego V, Escalera-Antezana JP, Méndez CA, Zambrano LI, Franco-Paredes C, Suárez JA, Rodriguez-Enciso HD, Balbin-Ramon GJ, Savio-Larriera E, Risquez A, Cimerman S. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Med Infect Dis. 2020 May-Jun;35:101613. doi: 10.1016/j.tmaid.2020.101613. Epub 2020 Feb 29. PMID: 32126292; PMCID: PMC7129040.
  7. https://coronavirus.gob.mx/wp-content/uploads/2020/07/Lineamientos-Reconversion-Hospitalaria_05042020_2.pdf
  8. Steenblock C, Schwarz PEH, Ludwig B, Linkermann A, Zimmet P, Kulebyakin K, Tkachuk VA, Markov AG, Lehnert H, de Angelis MH, Rietzsch H, Rodionov RN, Khunti K, Hopkins D, Birkenfeld AL, Boehm B, Holt RIG, Skyler JS, DeVries JH, Renard E, Eckel RH, Alberti KGMM, Geloneze B, Chan JC, Mbanya JC, Onyegbutulem HC, Ramachandran A, Basit A, Hassanein M, Bewick G, Spinas GA, Beuschlein F, Landgraf R, Rubino F, Mingrone G, Bornstein SR. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021 Nov;9(11):786-798. doi: 10.1016/S2213-8587(21)00244-8. Epub 2021 Oct 4. PMID: 34619105; PMCID: PMC8489878.
  9. Velarde-Ruiz Velasco JA, García-Jiménez ES, Remes-Troche JM. Hepatic manifestations and impact of COVID-19 on the cirrhotic patient. Rev Gastroenterol Mex (Engl Ed). 2020 Jul-Sep;85(3):303-311. English, Spanish. doi: 10.1016/j.rgmx.2020.05.002. Epub 2020 May 27. PMID: 32553772; PMCID: PMC7250745.
  10. Espinosa OA, Zanetti ADS, Antunes EF, Longhi FG, Matos TA, Battaglini PF. Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Rev Inst Med Trop Sao Paulo. 2020 Jun 22;62:e43. doi: 10.1590/S1678-9946202062043. PMID: 32578683; PMCID: PMC7310609.
  11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J. Características clínicas de 138 pacientes hospitalizados con neumonía infectada por el nuevo coronavirus de 2019 en Wuhan, China. JAMA. 2020; 323: 1061–1069.
  12. Caussy C, Wallet F, Laville M, Disse E. Obesity is Associated with Severe Forms of COVID-19. Obesity (Silver Spring). 2020 Jul;28(7):1175. doi: 10.1002/oby.22842. Epub 2020 May 21. Erratum in: Obesity (Silver Spring). 2020 Oct;28(10):1993. PMID: 32314861; PMCID: PMC7264509.
  13. Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020 Jul;16(7):341-342. doi: 10.1038/s41574-020-0364-6. PMID: 32327737; PMCID: PMC7187148.
  14. Ren H, Guo X, Palazón-Bru A, Yang P, Huo N, Wang R, Sun Y, Hu Q, Yang H, Xu G. Regional Differences in Epidemiological and Clinical Characteristics, Treatment, and Clinical Outcomes of COVID-19 in Wuhan and Remote Areas of Hubei Province. Front Med (Lausanne). 2021 Jul 15;8:667623. doi: 10.3389/fmed.2021.667623. PMID: 34336881; PMCID: PMC8319467.
  15. Rodríguez Nancy P. Distribution of the population vulnerable to COVID-19 in Havana, Cuba. Revista Cubana de Higiene y Epidemiología. 2020; 57:371 https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES
  16. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, Qin R, Wang H, Shen Y, Du K, Zhao L, Fan H, Luo S, Hu D. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020 Mar 31;36(7):e3319. doi: 10.1002/dmrr.3319. Epub ahead of print. PMID: 32233013; PMCID: PMC7228407.
  17. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, Labreuche J, Mathieu D, Pattou F, Jourdain M; LICORN and the Lille COVID-19 and Obesity study group. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity (Silver Spring). 2020 Jul;28(7):1195-1199. doi: 10.1002/oby.22831. Epub 2020 Jun 10. Erratum in: Obesity (Silver Spring). 2020 Oct;28(10):1994. PMID: 32271993; PMCID: PMC7262326.
  18. Pacheco-Pantoja E, Fernando A. Bravo F, Ángel E. ceballos-Cruz. COVID-19, diabetes, obesity and hypertension: 60 days of pandemic in Mexico. Rev Mex Endocrinol Metab Nutr. 2020; 7:68-79
  19. Calixto-Calderón B, María F. Vázquez-González, Martínez-Peláez R. Pre-existing comorbidity, the highest risk factor for poor prognosis of COVID19 among the Mexican population. DOI: https://doi.org/10.21640/ns.v13ie.2823
  20. Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3. PMID: 34418980; PMCID: PMC8380115.
  21. Slobdan P, Stuling T. Diabetes and covid-19. Springer Nature.2020 May; 132:356-361.
  22. https://datos.nexos.com.mx/la-letalidad-hospitalaria-por-covid-19-en-mexico-desigualdades-institucionales/
  23. Emara HM, Shoaib MR, El-Shafai W, Elwekeil M, Hemdan EE, Fouda MM, Taha TE, El-Fishawy AS, El-Rabaie EM, El-Samie FEA. Simultaneous Super-Resolution and Classification of Lung Disease Scans. Diagnostics (Basel). 2023 Apr 2;13(7):1319. doi: 10.3390/diagnostics13071319. PMID: 37046537; PMCID: PMC10093568.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?